Benchmark analyst Bill Sutherland raised the firm’s price target on CareCloud to $4.50 from $4 and keeps a Buy rating on the shares. CareCloud demonstrated further improvement in profitability with a 67% increase in adjusted EBITDA in Q2, notes the analyst, who now models a flattish sequential revenue trend for the remainder of this year and notes that revenue momentum is expected to improve in 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCLD:
- CareCloud Shareholders Address Preferred Stock Changes
- Support for Preferred Stock Proposal Hits a New High of 89%, Special Meeting Scheduled for September 11th
- CareCloud Enhances Investor Insights with Earnings Slides
- CareCloud reports Q2 adjusted EPS 18c, consensus (3c)
- CareCloud announces Glass Lewis recommends voting ‘Yes’